CTI BIOPHARMA CORP (CTIC) Stock Price, Quote, News and Overview

What is the stock price of CTI BIOPHARMA CORP today?

The current stock price of CTIC is 9.09 USD.

What is the ticker symbol for CTI BIOPHARMA CORP stock?

The exchange symbol of CTI BIOPHARMA CORP is CTIC and it is listed on the Nasdaq exchange.

On which exchange is CTIC stock listed?

CTIC stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for CTI BIOPHARMA CORP stock?

14 analysts have analysed CTIC and the average price target is 10.7 USD. This implies a price increase of 17.66% is expected in the next year compared to the current price of 9.09. Check the CTI BIOPHARMA CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is CTI BIOPHARMA CORP worth?

CTI BIOPHARMA CORP (CTIC) has a market capitalization of 1.20B USD. This makes CTIC a Small Cap stock.

How many employees does CTI BIOPHARMA CORP have?

CTI BIOPHARMA CORP (CTIC) currently has 128 employees.

What are the support and resistance levels for CTI BIOPHARMA CORP (CTIC) stock?

CTI BIOPHARMA CORP (CTIC) has a support level at 9.08 and a resistance level at 9.1. Check the full technical report for a detailed analysis of CTIC support and resistance levels.

Is CTI BIOPHARMA CORP (CTIC) expected to grow?

The Revenue of CTI BIOPHARMA CORP (CTIC) is expected to grow by 121.03% in the next year. Check the estimates tab for more information on the CTIC EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy CTI BIOPHARMA CORP (CTIC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of CTIC, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of CTIC, evaluating the profitability, health, valuation and growth aspects
• CTI BIOPHARMA CORP (CTIC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• CTI BIOPHARMA CORP (CTIC) Sales and EPS estimates to see what analysts future expectations are.
• CTI BIOPHARMA CORP (CTIC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• CTI BIOPHARMA CORP (CTIC) Insider and Institutional Ownership to learn about the owners and their transactions.
• CTI BIOPHARMA CORP (CTIC) Stock Chart to make your own analysis
• CTI BIOPHARMA CORP (CTIC) Latest news and press-releases to stay up to date.

Does CTI BIOPHARMA CORP (CTIC) stock pay dividends?

CTIC does not pay a dividend.

When does CTI BIOPHARMA CORP (CTIC) report earnings?

CTI BIOPHARMA CORP (CTIC) will report earnings on 2023-08-07, after the market close.

What is the Price/Earnings (PE) ratio of CTI BIOPHARMA CORP (CTIC)?

CTI BIOPHARMA CORP (CTIC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.58).

ChartMill assigns a fundamental rating of 3 / 10 to CTIC. Both the profitability and financial health of CTIC have multiple concerns.

Over the last trailing twelve months CTIC reported a non-GAAP Earnings per Share(EPS) of -0.58. The EPS increased by 52.46% compared to the year before.

ChartMill assigns a Buy % Consensus number of 76% to CTIC. The Buy consensus is the average rating of analysts ratings from 14 analysts.

For the next year, analysts expect an EPS growth of 66.63% and a revenue growth 121.03% for CTIC